SG144921A1 - Method and intermediates for the preparation of derivatives of n-(1- benzhydrylazetidin-3-yl)-n-phenylmethylsulphonamide - Google Patents
Method and intermediates for the preparation of derivatives of n-(1- benzhydrylazetidin-3-yl)-n-phenylmethylsulphonamideInfo
- Publication number
- SG144921A1 SG144921A1 SG200805168-2A SG2008051682A SG144921A1 SG 144921 A1 SG144921 A1 SG 144921A1 SG 2008051682 A SG2008051682 A SG 2008051682A SG 144921 A1 SG144921 A1 SG 144921A1
- Authority
- SG
- Singapore
- Prior art keywords
- phenylmethylsulphonamide
- benzhydrylazetidin
- intermediates
- derivatives
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0410845A FR2876689B1 (fr) | 2004-10-14 | 2004-10-14 | Nouveau procede et intermediaires de preparation de derives de n-(1-benzhydryl-azetidin-3-yl)-n-phenyl-methylsulfonamide |
Publications (1)
Publication Number | Publication Date |
---|---|
SG144921A1 true SG144921A1 (en) | 2008-08-28 |
Family
ID=34953744
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG200805167-4A SG144920A1 (en) | 2004-10-14 | 2005-10-10 | Method and intermediates for the preparation of derivatives of n-(1- benzhydrylazetidin-3-yl)-n-phenylmethylsulphonamide |
SG200805168-2A SG144921A1 (en) | 2004-10-14 | 2005-10-10 | Method and intermediates for the preparation of derivatives of n-(1- benzhydrylazetidin-3-yl)-n-phenylmethylsulphonamide |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG200805167-4A SG144920A1 (en) | 2004-10-14 | 2005-10-10 | Method and intermediates for the preparation of derivatives of n-(1- benzhydrylazetidin-3-yl)-n-phenylmethylsulphonamide |
Country Status (32)
Country | Link |
---|---|
US (3) | US7429668B2 (sl) |
EP (1) | EP1802571B1 (sl) |
JP (1) | JP4971986B2 (sl) |
KR (1) | KR20070063540A (sl) |
CN (1) | CN101039903A (sl) |
AR (1) | AR051389A1 (sl) |
AT (1) | ATE534624T1 (sl) |
AU (1) | AU2005293453A1 (sl) |
BR (1) | BRPI0516526A (sl) |
CA (1) | CA2581781A1 (sl) |
CR (1) | CR9008A (sl) |
CY (1) | CY1112390T1 (sl) |
DK (1) | DK1802571T3 (sl) |
EA (2) | EA012523B1 (sl) |
ES (1) | ES2378181T3 (sl) |
FR (1) | FR2876689B1 (sl) |
HR (1) | HRP20120168T1 (sl) |
IL (1) | IL182277A0 (sl) |
MA (1) | MA29005B1 (sl) |
ME (1) | ME01297B (sl) |
MX (1) | MX2007004483A (sl) |
NO (1) | NO20072431L (sl) |
PL (1) | PL1802571T3 (sl) |
PT (1) | PT1802571E (sl) |
RS (1) | RS52132B (sl) |
SG (2) | SG144920A1 (sl) |
SI (1) | SI1802571T1 (sl) |
TN (1) | TNSN07115A1 (sl) |
TW (1) | TW200626542A (sl) |
UY (1) | UY29165A1 (sl) |
WO (1) | WO2006040464A1 (sl) |
ZA (1) | ZA200703011B (sl) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2925050B1 (fr) * | 2007-12-14 | 2010-01-08 | Sanofi Aventis | Nouveau procede de preparation de derives d'azetidine |
JP5738854B2 (ja) * | 2009-06-29 | 2015-06-24 | メルツ・ファルマ・ゲーエムベーハー・ウント・コ・カーゲーアーアー | ネラメキサンの製造方法 |
JP5599878B2 (ja) * | 2009-06-29 | 2014-10-01 | メルツ・ファルマ・ゲーエムベーハー・ウント・コ・カーゲーアーアー | 1−アミノ−1,3,3,5,5−ペンタメチルシクロヘキサンを調製する方法 |
CN107089918B (zh) * | 2017-04-08 | 2020-06-16 | 迪嘉药业集团有限公司 | 一种盐酸二苯甲胺的制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9714129D0 (en) * | 1997-07-04 | 1997-09-10 | Pfizer Ltd | Azetidines |
US6566356B2 (en) * | 2000-03-03 | 2003-05-20 | Aventis Pharma S.A. | Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation |
FR2805817B1 (fr) * | 2000-03-03 | 2002-04-26 | Aventis Pharma Sa | Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation |
FR2814678B1 (fr) * | 2000-10-04 | 2002-12-20 | Aventis Pharma Sa | Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite |
-
2004
- 2004-10-14 FR FR0410845A patent/FR2876689B1/fr not_active Expired - Fee Related
-
2005
- 2005-10-10 PT PT05809316T patent/PT1802571E/pt unknown
- 2005-10-10 MX MX2007004483A patent/MX2007004483A/es active IP Right Grant
- 2005-10-10 EA EA200700842A patent/EA012523B1/ru not_active IP Right Cessation
- 2005-10-10 AT AT05809316T patent/ATE534624T1/de active
- 2005-10-10 CN CNA2005800350930A patent/CN101039903A/zh active Pending
- 2005-10-10 JP JP2007536213A patent/JP4971986B2/ja not_active Expired - Fee Related
- 2005-10-10 BR BRPI0516526-1A patent/BRPI0516526A/pt not_active IP Right Cessation
- 2005-10-10 KR KR1020077008412A patent/KR20070063540A/ko not_active Application Discontinuation
- 2005-10-10 AU AU2005293453A patent/AU2005293453A1/en not_active Withdrawn
- 2005-10-10 WO PCT/FR2005/002489 patent/WO2006040464A1/fr active Application Filing
- 2005-10-10 EA EA200801990A patent/EA200801990A1/ru unknown
- 2005-10-10 CA CA002581781A patent/CA2581781A1/fr not_active Abandoned
- 2005-10-10 RS RS20120060A patent/RS52132B/en unknown
- 2005-10-10 ZA ZA200703011A patent/ZA200703011B/xx unknown
- 2005-10-10 SI SI200531476T patent/SI1802571T1/sl unknown
- 2005-10-10 PL PL05809316T patent/PL1802571T3/pl unknown
- 2005-10-10 DK DK05809316.2T patent/DK1802571T3/da active
- 2005-10-10 EP EP05809316A patent/EP1802571B1/fr active Active
- 2005-10-10 ME MEP-2012-19A patent/ME01297B/me unknown
- 2005-10-10 SG SG200805167-4A patent/SG144920A1/en unknown
- 2005-10-10 ES ES05809316T patent/ES2378181T3/es active Active
- 2005-10-10 SG SG200805168-2A patent/SG144921A1/en unknown
- 2005-10-13 AR ARP050104295A patent/AR051389A1/es unknown
- 2005-10-13 TW TW094135609A patent/TW200626542A/zh unknown
- 2005-10-14 UY UY29165A patent/UY29165A1/es unknown
-
2007
- 2007-03-21 CR CR9008A patent/CR9008A/es not_active Application Discontinuation
- 2007-03-28 IL IL182277A patent/IL182277A0/en unknown
- 2007-03-28 US US11/692,462 patent/US7429668B2/en active Active
- 2007-03-28 TN TNP2007000115A patent/TNSN07115A1/fr unknown
- 2007-05-04 MA MA29868A patent/MA29005B1/fr unknown
- 2007-05-11 NO NO20072431A patent/NO20072431L/no not_active Application Discontinuation
-
2008
- 2008-08-20 US US12/194,644 patent/US7652154B2/en active Active
-
2009
- 2009-12-11 US US12/635,965 patent/US8071788B2/en active Active
-
2012
- 2012-02-20 HR HR20120168T patent/HRP20120168T1/hr unknown
- 2012-02-23 CY CY20121100184T patent/CY1112390T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL377861A1 (pl) | Podstawione pochodne aminowe oraz sposoby wykorzystania | |
SG147409A1 (en) | Amide derivatives | |
ECSP095220A (es) | Derivados de n-fenil-2-pirimidin-amina | |
ZA200509103B (en) | Process and intermediates for the preparation of 3-(amino)-3-cyclobutylmethyl-2-hydroxy-propionamideor salts thereof | |
EE200300325A (et) | Asendatud amiini derivaadid ning nende kasutamismeetodid | |
ATE495162T1 (de) | Azabicyclo-octan und nonan derivate mit ddp-iv hemmender wirkung | |
PL376524A1 (pl) | Nowe hydroksyindole, ich zastosowanie jako inhibitorów fosfodiesterazy 4 i sposób ich wytwarzania | |
EP1572262A3 (en) | Method of delivering local anesthesia | |
AU2003284115A1 (en) | Method of delivering local anesthesia | |
AU2006224295A8 (en) | N- (N-sulfonylaminomethyl) cyclopropanecarboxamide derivatives useful for the treatment of pain | |
IL185176A0 (en) | Intermediates used for the preparation of quinazoline derivatives and active metabolites of phosphnooxy quinazoline derivatives | |
EP1364943A4 (en) | NEW CYSTINE DERIVATIVES AND INHIBITORS FOR THE ACTIVATION OF IGNITION FACTORS | |
IL178156A0 (en) | Intermediates for the preparation of pramipexole | |
TW200624426A (en) | BACE inhibitors | |
AU2003220558A1 (en) | Amide compounds and methods of using the same | |
IL223579A0 (en) | Synthesis of amines and intermediates for the synthesis thereof | |
NO20051393L (no) | Prosess og intermediater for fremstilling av tienopyrrol-derivater | |
IL213615A (en) | N - History (phenyl preserved in position 5 and converted in nitro in position 2) Reliable and methods for making h - benzimideol preserved in methyl in position 1 and also used in position 6 | |
GB0402099D0 (en) | Method of attaching hair-thickening hair material and hair-thickening hair material fixture used for the method | |
TW200508233A (en) | Chk-1 inhibitors | |
TW200613308A (en) | Cyclobutanetetracarboxylate compound and preparation method thereof | |
DK1558246T3 (da) | Prolinderivater med affinitet for calcimkanalens alpha-2-delta subunit | |
PL1786759T3 (pl) | Nowe pochodne 3,5-seko-4-norcholestanowe i ich zastosowanie | |
SG144921A1 (en) | Method and intermediates for the preparation of derivatives of n-(1- benzhydrylazetidin-3-yl)-n-phenylmethylsulphonamide | |
HRP20040920A2 (en) | Novel form of n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine |